Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Gamma-Aminobutyric Acid and Valproic Acid

Research Papers that Mention the Interaction

Currently, 2 antiepileptic drugs, valproate (VPA) and vigabatrin, gamma‐vinyl GABA (GVG), are available, which are supposed to inhibit the degradation of GABA.
Acta neurologica Scandinavica  •  1988  |  View Paper
Valproic acid increases synaptosomal GABA concentrations, thus affecting all types of GABA receptors.
Alimentary pharmacology & therapeutics  •  2003  |  View Paper
Sodium valproate (SV) inhibits GABA transaminase so increasing the endogenous GABAergic tone.
Journal of endocrinological investigation  •  1997  |  View Paper
Following treatment with divalproex sodium , plasma GABA levels decreased significantly (p < .05), compared to placebo.
Higher pretreatment plasma GABA levels were significantly (p = .04) related to a better clinical response to divalproex (n = 19).
Biological Psychiatry  •  1996  |  View Paper
Although VPA increases brain gamma-aminobutyric acid (GABA) concentrations, the anticonvulsant effect appears to be more closely associated with a reduction in brain concentrations of aspartic acid (Chapman et al. 1982, 1983; Schechter et al. 1978).
Biological Psychiatry  •  1985  |  View Paper
The effect of sodium valproate , a drug which has been demonstrated to increase gamma-aminobutyric acid levels in the CNS, on tardive dyskinesia and psychiatric symptoms was investigated in a double-blind cross-over study on 32 chronic psychiatric patients.
The British journal of psychiatry : the journal of mental science  •  1976  |  View Paper
At maximum dose levels, combined DPA and GABA treatment led to an apparent increase in the central turnover of both dopamine and serotonin, as estimated by the oral probenecid-loading test.
Neurology  •  1976  |  View Paper
Sodium valproate interacts with biological systems through different mechanisms such as activation of gamma-aminobutyric acid (GABA)-sensitive chloride channels and inhibition of histone deacetylase.
The Journal of surgical research  •  2019  |  View Paper
Focused studies uncovered the potential of valproic acid to interfere with multiple regulatory mechanisms including histone deacetylases, GSK3 alpha and beta, Akt, the ERK pathway, the phosphoinositol pathway, the tricarboxylic acid cycle, GABA , and the OXPHOS system.
Folia biologica  •  2007  |  View Paper
The inhibitory action of DPA on GABA degradation, resulting in an enhanced release of GABA , is probably responsible for this behavioral effect, since GABA antagonists, like bicuculline and picrotoxin, have been shown to suppress this behavior.
Psychopharmacology  •  2004  |  View Paper
Show More